相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Deficiency of plasminogen activator inhibitor 2 in plasma of patients with hereditary angioedema with normal C1 inhibitor levels
Kusumam Joseph et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Phase II study results of a replacement therapy for hereditary angioedema with subcutaneous C1-inhibitor concentrate
B. L. Zuraw et al.
ALLERGY (2015)
Elevated D-dimers in attacks of hereditary angioedema are not associated with increased thrombotic risk
A. Reshef et al.
ALLERGY (2015)
Hereditary angioedema with normal C1-INH with versus without specific F12 gene mutations
K. Bork et al.
ALLERGY (2015)
C1 inhibitor deficiency: 2014 United Kingdom consensus document
H. J. Longhurst et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2015)
Subcutaneous Human C1-Inhibitor with Recombinant Human Hyaluronidase for the Prevention of Angioedema Attacks in Patients with Hereditary Angioedema: Results of a Randomized, Double-Blind, Dose-Ranging, Crossover Study
Marc A. Riedl et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Defective glycosylation of coagulation factor XII underlies hereditary angioedema type III
Jenny Bjoerkqvist et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
The factor XIIa blocking antibody 3F7: a safe anticoagulant with anti-inflammatory activities
Marie Worm et al.
ANNALS OF TRANSLATIONAL MEDICINE (2015)
A Consensus Parameter for the Evaluation and Management of Angioedema in the Emergency DepartmentUn Parametro de Consenso para la Evaluacion y Tratamiento del Angioedema en el Servicio de Urgencias
Joseph J. Moellman et al.
ACADEMIC EMERGENCY MEDICINE (2014)
Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group
M. Cicardi et al.
ALLERGY (2014)
The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine
Peter D. Stenson et al.
HUMAN GENETICS (2014)
Guidance for diagnosis and treatment of acute angioedema in the emergency department: consensus statement by a panel of Italian experts
Marco Cicardi et al.
INTERNAL AND EMERGENCY MEDICINE (2014)
A Factor XIIa Inhibitory Antibody Provides Thromboprotection in Extracorporeal Circulation Without Increasing Bleeding Risk
Magnus Larsson et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Pharmacokinetics of plasma-derived C1-esterase inhibitor after subcutaneous versus intravenous administration in subjects with mild or moderate hereditary angioedema: the PASSION study
Inmaculada Martinez-Saguer et al.
TRANSFUSION (2014)
Canadian hereditary angioedema guideline
Stephen Betschel et al.
ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY (2014)
Signs and symptoms preceding acute attacks of hereditary angioedema: Results of three recent surveys
Avner Reshef et al.
ALLERGY AND ASTHMA PROCEEDINGS (2013)
Acute angioedema: recognition and management in the emergency department
Thiagarajan Jaiganesh et al.
EUROPEAN JOURNAL OF EMERGENCY MEDICINE (2013)
Factor XII-independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II
Kusumam Joseph et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Discovery and Characterization of a Fully Human Monoclonal Antibody Inhibitor of Plasma Kallikrein for the Treatment of Plasma Kallikrein-Mediated Edema
Daniel Sexton et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
A focused parameter update: Hereditary angioedema, acquired C1 inhibitor deficiency, and angiotensin-converting enzyme inhibitor-associated angioedema
Bruce L. Zuraw et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
US Hereditary Angioedema Association Medical Advisory Board 2013 Recommendations for the Management of Hereditary Angioedema Due to C1 Inhibitor Deficiency
Bruce L. Zuraw et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2013)
Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group
M. Cicardi et al.
ALLERGY (2012)
Hereditary angioedema with normal C1 inhibitor function: Consensus of an international expert panel
Bruce L. Zuraw et al.
ALLERGY AND ASTHMA PROCEEDINGS (2012)
Recombinant C1-Inhibitor Effects on Coagulation and Fibrinolysis in Patients with Hereditary Angioedema
Anurag Relan et al.
BIODRUGS (2012)
Alterations of coagulation and fibrinolysis in patients with angioedema due to C1-inhibitor deficiency
M. van Geffen et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2012)
Treatment of hereditary angioedema with nanofiltered C1-esterase inhibitor concentrate (Cetor®): Multi-center phase II and III studies to assess pharmacokinetics, clinical efficacy and safety
J. J. Hofstra et al.
CLINICAL IMMUNOLOGY (2012)
Hereditary angioedema (HAE) in children and adolescents-a consensus on therapeutic strategies
V. Wahn et al.
EUROPEAN JOURNAL OF PEDIATRICS (2012)
International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiency
Teresa Caballero et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
WAO Guideline for the Management of Hereditary Angioedema
Timothy Craig et al.
WORLD ALLERGY ORGANIZATION JOURNAL (2012)
Randomized placebo-controlled trial of the bradykinin B2 receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial
William R. Lumry et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2011)
Selective depletion of plasma prekallikrein or coagulation factor XII inhibits thrombosis in mice without increased risk of bleeding
Alexey S. Revenko et al.
BLOOD (2011)
Ecallantide (DX-88) for acute hereditary angioedema attacks: Integrated analysis of 2 double-blind, phase 3 studies
Albert L. Sheffer et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
TREATMENT OF HEREDITARY ANGIONEUROTIC OEDEMA WITH TRANEXAMIC ACID
G. Blohmé
ACTA MEDICA SCANDINAVICA (2010)
Genius at Work: Osler's 1888 Article on Hereditary Angioedema
Richard D. deShazo et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2010)
EDEMA4: a phase 3, double-blind study of subcutaneous ecallantide treatment for acute attacks of hereditary angioedema
Robyn J. Levy et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2010)
Hereditary angioneurotic oedema: characterization of plasma kinin and vascular permeability-enhancing activities
L. R. SHOEMAKER et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema
Bruce Zuraw et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Ecallantide for the Treatment of Acute Attacks in Hereditary Angioedema
Marco Cicardi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Nanofiltered C1 Inhibitor Concentrate for Treatment of Hereditary Angioedema
Bruce L. Zuraw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Icatibant, a New Bradykinin-Receptor Antagonist, in Hereditary Angioedema
M. Cicardi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Case report: first successful application of preimplantation genetic diagnosis for hereditary angiooedema
Rosa Bautista-Llacer et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2010)
Plasma biomarkers of acute attacks in patients with angioedema due to C1-inhibitor deficiency
M. Cugno et al.
ALLERGY (2009)
Variability of prodromal signs and symptoms associated with hereditary angioedema attacks: A literature review
John G. Kemp et al.
ALLERGY AND ASTHMA PROCEEDINGS (2009)
Frequency, timing, and type of prodromal symptoms associated with hereditary angioedema attacks
Michael J. Prematta et al.
ALLERGY AND ASTHMA PROCEEDINGS (2009)
Dipeptidyl Peptidase-IV Inhibitor Use Associated With Increased Risk of ACE Inhibitor-Associated Angioedema
Nancy J. Brown et al.
HYPERTENSION (2009)
Novel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiency
Fleur Bossi et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks
Timothy J. Craig et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Studies of the mechanisms of bradykinin generation in hereditary angioedema plasma
Kusumam Joseph et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2008)
Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema
Tom Bowen et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2008)
Results of a 2-Stage, Phase 3 Pivotal Trial, EDEMA3®: A Study of Subcutaneous DX-88 (Ecallantide), a Plasma Kallikrein Inhibitor, in Patients with Hereditary Angioedema (HAE)
R LEVY et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant)
Konrad Bork et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III
Sven Cichon et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor
G Dewald et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Defective thrombus formation in mice lacking coagulation factor XII
T Renné et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
C1 inhibitor deficiency: consensus document
MM Gompels et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2005)
HAEdb: A novel interactive, locus-specific mutation database for the C1 inhibitor gene
L Kalmar et al.
HUMAN MUTATION (2005)
Canadian 2003 international consensus algorithm for the diagnosis, therapy, and management of hereditary angioedema
T Bowen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond
Angelo Agostoni et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
N- and O-glycans of recombinant human C1 inhibitor expressed in the milk of transgenic rabbits
K Koles et al.
GLYCOBIOLOGY (2004)
Erythema marginatum and hereditary angioedema
JC Starr et al.
SOUTHERN MEDICAL JOURNAL (2004)
Management of hereditary angioedema: a Canadian approach
T Bowen et al.
TRANSFUSION AND APHERESIS SCIENCE (2003)
Bradykinin and the pathophysiology of angioedema
M Cugno et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2003)
The Neil Smith Memorial Lecture: John Laws Milton. The founder of St John's Hospital for Diseases of the Skin
MM Black
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2003)
Increased vascular permeability in C1 men inhibitor-deficient mice mediated by the bradykinin type 2 receptor
ED Han et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
A multicentre evaluation of the diagnostic efficiency of serological investigations for C1 inhibitor deficiency
MM Gompels et al.
JOURNAL OF CLINICAL PATHOLOGY (2002)
Angiooedema due to acquired deficiency of C1-esterase inhibitor associated with leucocytoclastic vasculitis
H Farkas et al.
ACTA DERMATO-VENEREOLOGICA (2001)
Hereditary angioedema with normal C1-inhibitor activity in women
K Bork et al.
LANCET (2000)
分享论文
